View Future GrowthChemanex 과거 순이익 실적과거 기준 점검 2/6Chemanex은 연평균 14.4%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 수입이 6.7% 증가했습니다. 매출은 연평균 12.4%의 비율로 증가했습니다. Chemanex의 자기자본이익률은 2.8%이고 순이익률은 11.9%입니다.핵심 정보14.39%순이익 성장률14.37%주당순이익(EPS) 성장률Chemicals 산업 성장률33.74%매출 성장률12.37%자기자본이익률2.84%순이익률11.91%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • May 24Full year 2025 earnings released: EPS: LK₨7.48 (vs LK₨7.12 in FY 2024)Full year 2025 results: EPS: LK₨7.48 (up from LK₨7.12 in FY 2024). Revenue: LK₨873.5m (up 11% from FY 2024). Net income: LK₨117.6m (up 5.1% from FY 2024). Profit margin: 14% (in line with FY 2024). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 37% per year, which means it is well ahead of earnings.Reported Earnings • Jan 21Third quarter 2025 earnings released: EPS: LK₨1.84 (vs LK₨2.70 in 3Q 2024)Third quarter 2025 results: EPS: LK₨1.84 (down from LK₨2.70 in 3Q 2024). Revenue: LK₨253.4m (up 17% from 3Q 2024). Net income: LK₨29.0m (down 32% from 3Q 2024). Profit margin: 11% (down from 20% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Oct 25Second quarter 2025 earnings released: EPS: LK₨1.07 (vs LK₨0.092 loss in 2Q 2024)Second quarter 2025 results: EPS: LK₨1.07 (up from LK₨0.092 loss in 2Q 2024). Revenue: LK₨206.3m (up 12% from 2Q 2024). Net income: LK₨16.8m (up LK₨18.2m from 2Q 2024). Profit margin: 8.1% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 02First quarter 2025 earnings released: EPS: LK₨2.71 (vs LK₨0.90 in 1Q 2024)First quarter 2025 results: EPS: LK₨2.71 (up from LK₨0.90 in 1Q 2024). Revenue: LK₨173.4m (up 6.1% from 1Q 2024). Net income: LK₨42.5m (up 199% from 1Q 2024). Profit margin: 25% (up from 8.7% in 1Q 2024). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Reported Earnings • May 19Full year 2024 earnings released: EPS: LK₨7.11 (vs LK₨10.82 in FY 2023)Full year 2024 results: EPS: LK₨7.11 (down from LK₨10.82 in FY 2023). Revenue: LK₨789.0m (down 26% from FY 2023). Net income: LK₨111.7m (down 34% from FY 2023). Profit margin: 14% (down from 16% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Reported Earnings • Jan 18Third quarter 2024 earnings released: EPS: LK₨2.70 (vs LK₨1.42 in 3Q 2023)Third quarter 2024 results: EPS: LK₨2.70 (up from LK₨1.42 in 3Q 2023). Revenue: LK₨217.5m (down 1.6% from 3Q 2023). Net income: LK₨42.4m (up 90% from 3Q 2023). Profit margin: 20% (up from 10% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.모든 업데이트 보기Recent updatesBoard Change • Feb 13High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Chairman of the Board Sumithra Anura Ekanayake is the most experienced director on the board, commencing their role in 2016. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.New Risk • Oct 14New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.4% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (22% accrual ratio). Market cap is less than US$10m (LK₨2.90b market cap, or US$9.58m). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (12% net profit margin). Revenue is less than US$5m (LK₨930m revenue, or US$3.1m).Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to LK₨194, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 10x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 136% over the past three years.New Risk • Aug 13New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (22% accrual ratio). Market cap is less than US$10m (LK₨2.67b market cap, or US$8.86m). Minor Risks Profit margins are more than 30% lower than last year (12% net profit margin). Revenue is less than US$5m (LK₨930m revenue, or US$3.1m).Valuation Update With 7 Day Price Move • Jun 30Investor sentiment improves as stock rises 15%After last week's 15% share price gain to LK₨165, the stock trades at a trailing P/E ratio of 22x. Average trailing P/E is 9x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 249% over the past three years.Upcoming Dividend • Jun 24Upcoming dividend of LK₨2.50 per shareEligible shareholders must have bought the stock before 01 July 2025. Payment date: 21 July 2025. Payout ratio is a comfortable 33% and the cash payout ratio is 80%. Trailing yield: 1.7%. Lower than top quartile of Sri Lankan dividend payers (5.4%). Lower than average of industry peers (4.7%).Declared Dividend • May 29Dividend of LK₨2.50 announcedDividend of LK₨2.50 is the same as last year. Ex-date: 1st July 2025 Payment date: 21st July 2025 Dividend yield will be 1.6%, which is lower than the industry average of 8.6%. Sustainability & Growth Dividend is covered by both earnings (33% earnings payout ratio) and cash flows (56% cash payout ratio). The dividend has increased by an average of 9.6% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 63% to shift the payout ratio to a potentially unsustainable range, which is more than the 12% EPS decline seen over the last 5 years.공시 • May 28Chemanex PLC announces Annual dividend, payable on July 21, 2025Chemanex PLC announced Annual dividend of LKR 2.5000 per share payable on July 21, 2025, ex-date on July 01, 2025 and record date on July 02, 2025.공시 • May 27Chemanex PLC, Annual General Meeting, Jun 30, 2025Chemanex PLC, Annual General Meeting, Jun 30, 2025.Reported Earnings • May 24Full year 2025 earnings released: EPS: LK₨7.48 (vs LK₨7.12 in FY 2024)Full year 2025 results: EPS: LK₨7.48 (up from LK₨7.12 in FY 2024). Revenue: LK₨873.5m (up 11% from FY 2024). Net income: LK₨117.6m (up 5.1% from FY 2024). Profit margin: 14% (in line with FY 2024). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 37% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Feb 17Investor sentiment improves as stock rises 15%After last week's 15% share price gain to LK₨174, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 8x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 139% over the past three years.Reported Earnings • Jan 21Third quarter 2025 earnings released: EPS: LK₨1.84 (vs LK₨2.70 in 3Q 2024)Third quarter 2025 results: EPS: LK₨1.84 (down from LK₨2.70 in 3Q 2024). Revenue: LK₨253.4m (up 17% from 3Q 2024). Net income: LK₨29.0m (down 32% from 3Q 2024). Profit margin: 11% (down from 20% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jan 02Investor sentiment improves as stock rises 16%After last week's 16% share price gain to LK₨185, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 7x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 151% over the past three years.Valuation Update With 7 Day Price Move • Dec 17Investor sentiment improves as stock rises 26%After last week's 26% share price gain to LK₨123, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 7x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 82% over the past three years.New Risk • Nov 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Sri Lankan stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 8.9% per year over the past 5 years. High level of non-cash earnings (27% accrual ratio). Market cap is less than US$10m (LK₨1.37b market cap, or US$4.71m). Minor Risks Dividend is not well covered by cash flows (382% cash payout ratio). Share price has been volatile over the past 3 months (5.4% average weekly change). Revenue is less than US$5m (LK₨821m revenue, or US$2.8m).Reported Earnings • Oct 25Second quarter 2025 earnings released: EPS: LK₨1.07 (vs LK₨0.092 loss in 2Q 2024)Second quarter 2025 results: EPS: LK₨1.07 (up from LK₨0.092 loss in 2Q 2024). Revenue: LK₨206.3m (up 12% from 2Q 2024). Net income: LK₨16.8m (up LK₨18.2m from 2Q 2024). Profit margin: 8.1% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 02First quarter 2025 earnings released: EPS: LK₨2.71 (vs LK₨0.90 in 1Q 2024)First quarter 2025 results: EPS: LK₨2.71 (up from LK₨0.90 in 1Q 2024). Revenue: LK₨173.4m (up 6.1% from 1Q 2024). Net income: LK₨42.5m (up 199% from 1Q 2024). Profit margin: 25% (up from 8.7% in 1Q 2024). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.공시 • May 31Chemanex PLC, Annual General Meeting, Jun 28, 2024Chemanex PLC, Annual General Meeting, Jun 28, 2024.Declared Dividend • May 30Dividend of LK₨2.50 announcedDividend of LK₨2.50 is the same as last year. Ex-date: 1st July 2024 Payment date: 18th July 2024 Dividend yield will be 2.9%, which is lower than the industry average of 8.6%. Sustainability & Growth Dividend is covered by earnings (58% earnings payout ratio) but not covered by cash flows (124% cash payout ratio). The dividend has increased by an average of 9.6% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 4.3% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Reported Earnings • May 19Full year 2024 earnings released: EPS: LK₨7.11 (vs LK₨10.82 in FY 2023)Full year 2024 results: EPS: LK₨7.11 (down from LK₨10.82 in FY 2023). Revenue: LK₨789.0m (down 26% from FY 2023). Net income: LK₨111.7m (down 34% from FY 2023). Profit margin: 14% (down from 16% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Apr 30Investor sentiment improves as stock rises 17%After last week's 17% share price gain to LK₨85.00, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 6x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 31% over the past three years.Reported Earnings • Jan 18Third quarter 2024 earnings released: EPS: LK₨2.70 (vs LK₨1.42 in 3Q 2023)Third quarter 2024 results: EPS: LK₨2.70 (up from LK₨1.42 in 3Q 2023). Revenue: LK₨217.5m (down 1.6% from 3Q 2023). Net income: LK₨42.4m (up 90% from 3Q 2023). Profit margin: 20% (up from 10% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.Reported Earnings • Oct 21Second quarter 2024 earnings released: LK₨0.092 loss per share (vs LK₨3.36 profit in 2Q 2023)Second quarter 2024 results: LK₨0.092 loss per share (down from LK₨3.36 profit in 2Q 2023). Revenue: LK₨183.8m (down 48% from 2Q 2023). Net loss: LK₨1.40m (down 103% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.New Risk • Jul 28New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Sri Lankan stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.4% average weekly change). Earnings have declined by 27% per year over the past 5 years. Market cap is less than US$10m (LK₨1.41b market cap, or US$4.29m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (10% net profit margin). Revenue is less than US$5m (LK₨971m revenue, or US$3.0m).Reported Earnings • Jul 21First quarter 2024 earnings released: EPS: LK₨0.90 (vs LK₨5.25 in 1Q 2023)First quarter 2024 results: EPS: LK₨0.90 (down from LK₨5.25 in 1Q 2023). Revenue: LK₨163.5m (down 36% from 1Q 2023). Net income: LK₨14.2m (down 83% from 1Q 2023). Profit margin: 8.7% (down from 32% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Jun 27Upcoming dividend of LK₨2.50 per share at 3.6% yieldEligible shareholders must have bought the stock before 04 July 2023. Payment date: 24 July 2023. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 3.6%. Lower than top quartile of Sri Lankan dividend payers (8.4%). Lower than average of industry peers (8.3%).공시 • Jun 07Chemanex PLC, Annual General Meeting, Jun 30, 2023Chemanex PLC, Annual General Meeting, Jun 30, 2023, at 09:30 Sri Lanka Standard Time. Location: 9th Floor, Auditorium of Commercial Bank of Ceylon PLC, No.01, Union Place Colombo 02 Sri Lanka Agenda: To receive and adopt the statements of accounts of the company and of the group for the year ended 31st March 2023 together with the reports of the directors and auditors thereon; to declare a dividend as recommended by the directors; to reappoint Mr. E M M Boyagoda, who attained the age of 70 years on 29th April 2021, by passing the following Resolution of directors in terms of Section 211 of the Companies Act No. 7 of 2007; to reappoint M/s. Ernst & Young, Chartered Accountants as Auditors of the company and to authorise the directors to determine their remuneration; and to vote a sum as donations.Reported Earnings • May 26Full year 2023 earnings released: EPS: LK₨10.82 (vs LK₨6.20 in FY 2022)Full year 2023 results: EPS: LK₨10.82 (up from LK₨6.20 in FY 2022). Revenue: LK₨1.06b (up 66% from FY 2022). Net income: LK₨169.9m (up 75% from FY 2022). Profit margin: 16% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Jan 18Third quarter 2023 earnings released: EPS: LK₨1.42 (vs LK₨1.52 in 3Q 2022)Third quarter 2023 results: EPS: LK₨1.42 (down from LK₨1.52 in 3Q 2022). Revenue: LK₨221.0m (up 37% from 3Q 2022). Net income: LK₨22.3m (down 6.7% from 3Q 2022). Profit margin: 10% (down from 15% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.Board Change • Dec 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Independent Director Ekanayake Mudiyanselage Boyagoda was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Nov 21Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to LK₨62.00, the stock trades at a trailing P/E ratio of 5.1x. Average trailing P/E is 4x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 14% over the past three years.Board Change • Nov 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Independent Director Ekanayake Mudiyanselage Boyagoda was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 21Second quarter 2023 earnings released: EPS: LK₨3.36 (vs LK₨1.37 in 2Q 2022)Second quarter 2023 results: EPS: LK₨3.36 (up from LK₨1.37 in 2Q 2022). Revenue: LK₨351.2m (up 120% from 2Q 2022). Net income: LK₨52.8m (up 147% from 2Q 2022). Profit margin: 15% (up from 13% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to LK₨89.00, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 5x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 75% over the past three years.Valuation Update With 7 Day Price Move • Aug 04Investor sentiment improved over the past weekAfter last week's 22% share price gain to LK₨64.50, the stock trades at a trailing P/E ratio of 6.4x. Average trailing P/E is 5x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 9.5% over the past three years.Reported Earnings • Jul 21First quarter 2023 earnings released: EPS: LK₨5.25 (vs LK₨1.32 in 1Q 2022)First quarter 2023 results: EPS: LK₨5.25 (up from LK₨1.32 in 1Q 2022). Revenue: LK₨256.4m (up 81% from 1Q 2022). Net income: LK₨82.5m (up 296% from 1Q 2022). Profit margin: 32% (up from 15% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Jun 24Upcoming dividend of LK₨2.00 per shareEligible shareholders must have bought the stock before 01 July 2022. Payment date: 22 July 2022. Payout ratio is a comfortable 32% but the company is not cash flow positive. Trailing yield: 4.0%. Lower than top quartile of Sri Lankan dividend payers (9.4%). Lower than average of industry peers (7.9%).Board Change • Jun 15Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Independent Director Ekanayake Mudiyanselage Boyagoda was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공시 • Jun 04Chemanex PLC, Annual General Meeting, Jun 30, 2022Chemanex PLC, Annual General Meeting, Jun 30, 2022, at 09:30 Sri Lanka Standard Time. Location: 199, Kew Road, Colombo 2 Colombo Sri Lanka Agenda: To receive and adopt the Statements of Accounts of the Company and of the Group for the year ended 31st March 2022 together with the Reports of the Directors and Auditors thereon; to consider dividend; to consider re-election of directors; to consider re-appointing M/s. Ernst & Young, Chartered Accountants as Auditors of the Company and to authorize the Directors to determine their remuneration; and to consider such other matters.Reported Earnings • May 23Full year 2022 earnings released: EPS: LK₨6.20 (vs LK₨1.22 in FY 2021)Full year 2022 results: EPS: LK₨6.20 (up from LK₨1.22 in FY 2021). Revenue: LK₨639.7m (up 45% from FY 2021). Net income: LK₨97.4m (up 409% from FY 2021). Profit margin: 15% (up from 4.3% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • May 19Investor sentiment improved over the past weekAfter last week's 15% share price gain to LK₨65.00, the stock trades at a trailing P/E ratio of 14.6x. Average trailing P/E is 7x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 47% over the past three years.Valuation Update With 7 Day Price Move • Mar 29Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to LK₨61.60, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 8x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 11% over the past three years.Reported Earnings • Jan 23Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: LK₨1.52 (up from LK₨0.98 loss in 3Q 2021). Revenue: LK₨161.5m (up 42% from 3Q 2021). Net income: LK₨23.9m (up LK₨39.4m from 3Q 2021). Profit margin: 15% (up from net loss in 3Q 2021). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance.Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to LK₨115, the stock trades at a trailing P/E ratio of 59.1x. Average trailing P/E is 11x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 154% over the past three years.Reported Earnings • Oct 23Second quarter 2022 earnings released: EPS LK₨1.37 (vs LK₨1.21 in 2Q 2021)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: LK₨159.7m (up 19% from 2Q 2021). Net income: LK₨21.4m (up 13% from 2Q 2021). Profit margin: 13% (in line with 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance.Reported Earnings • Jul 22First quarter 2022 earnings released: EPS LK₨1.32 (vs LK₨0.74 in 1Q 2021)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2022 results: Revenue: LK₨141.8m (up 69% from 1Q 2021). Net income: LK₨20.8m (up 78% from 1Q 2021). Profit margin: 15% (in line with 1Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.Upcoming Dividend • Jun 25Upcoming dividend of LK₨1.00 per shareEligible shareholders must have bought the stock before 01 July 2021. Payment date: 22 July 2021. Trailing yield: 1.3%. Lower than top quartile of Sri Lankan dividend payers (5.5%). Lower than average of industry peers (5.0%).공시 • May 22+ 1 more updateChemanex PLC Recommends Final Dividend for the Year Ended March 31, 2021, Payable on 22 July 2021The Board of Directors of Chemanex PLC recommended a final dividend of LKR 1.00 per share amounting to LKR 15.71 million on the issued capital of Ordinary Shares for the year ended March 31, 2021, which is payable on 22 July 2021 if approved by the shareholders at the Annual General Meeting.Is New 90 Day High Low • Feb 23New 90-day low: LK₨79.70The company is down 9.0% from its price of LK₨87.70 on 25 November 2020. The Sri Lankan market is up 26% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 59% over the same period.Is New 90 Day High Low • Jan 27New 90-day high: LK₨103The company is up 51% from its price of LK₨67.90 on 29 October 2020. The Sri Lankan market is up 55% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 122% over the same period.Is New 90 Day High Low • Jan 12New 90-day high: LK₨93.10The company is up 33% from its price of LK₨69.90 on 14 October 2020. The Sri Lankan market is up 24% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 40% over the same period.Is New 90 Day High Low • Nov 23New 90-day high: LK₨92.60The company is up 63% from its price of LK₨56.70 on 25 August 2020. The Sri Lankan market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 53% over the same period.Valuation Update With 7 Day Price Move • Nov 23Market bids up stock over the past weekAfter last week's 33% share price gain to LK₨92.60, the stock is trading at a trailing P/E ratio of 6.8x, up from the previous P/E ratio of 5.1x. This compares to an average P/E of 8x in the Chemicals industry in Sri Lanka. Total returns to shareholders over the past three years are 91%.Valuation Update With 7 Day Price Move • Oct 20Market bids up stock over the past weekAfter last week's 18% share price gain to LK₨77.00, the stock is trading at a trailing P/E ratio of 5.7x, up from the previous P/E ratio of 4.8x. This compares to an average P/E of 9x in the Chemicals industry in Sri Lanka. Total returns to shareholders over the past three years are 45%.Is New 90 Day High Low • Oct 15New 90-day high: LK₨76.20The company is up 62% from its price of LK₨46.90 on 17 July 2020. The Sri Lankan market is up 20% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 76% over the same period.Valuation Update With 7 Day Price Move • Oct 15Market bids up stock over the past weekAfter last week's 20% share price gain to LK₨76.20, the stock is trading at a trailing P/E ratio of 5.6x, up from the previous P/E ratio of 4.7x. This compares to an average P/E of 7x in the Chemicals industry in Sri Lanka. Total returns to shareholders over the past three years are 45%.Is New 90 Day High Low • Sep 24New 90-day high: LK₨64.00The company is up 20% from its price of LK₨53.20 on 26 June 2020. The Sri Lankan market is up 13% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 50% over the same period.매출 및 비용 세부 내역Chemanex가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이COSE:CHMX.N0000 매출, 비용 및 순이익 (LKR Millions)날짜매출순이익일반관리비연구개발비31 Dec 251,066127145030 Sep 251,009114148030 Jun 25930107146031 Mar 25874118126031 Dec 2485714592030 Sep 2482115857030 Jun 2479914071031 Mar 2478911291031 Dec 2380068142030 Sep 2380347180030 Jun 23971102170031 Mar 231,064170155031 Dec 221,005189135030 Sep 22946190111030 Jun 2275415994031 Mar 226409787031 Dec 215737084030 Sep 215253182030 Jun 214992869031 Mar 214411971031 Dec 204464873030 Sep 204366882030 Jun 2040221399031 Mar 2039622797031 Dec 19398234101030 Sep 1940025999030 Jun 194319294031 Mar 194609190031 Dec 1850049254030 Sep 18582375202030 Jun 18650431229031 Mar 18724413259031 Dec 17391-1242030 Sep 1755563150030 Jun 176399141031 Mar 1782427139031 Dec 161,36832196030 Sep 161,39522158030 Jun 161,46764164031 Mar 161,44446168031 Dec 151,41711177030 Sep 151,37552181030 Jun 151,34361920양질의 수익: CHMX.N0000는 고품질 수익을 보유하고 있습니다.이익 마진 증가: CHMX.N0000의 현재 순 이익률 (11.9%)은 지난해 (16.9%)보다 낮습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: CHMX.N0000의 수익은 지난 5년 동안 연평균 14.4% 증가했습니다.성장 가속화: CHMX.N0000은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: CHMX.N0000은 지난 1년 동안 수익이 감소(-12.4%)하여 Chemicals 업계 평균(8.5%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: CHMX.N0000의 자본 수익률(2.8%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 20:04종가2026/05/22 00:00수익2025/12/31연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Chemanex PLC는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • May 24Full year 2025 earnings released: EPS: LK₨7.48 (vs LK₨7.12 in FY 2024)Full year 2025 results: EPS: LK₨7.48 (up from LK₨7.12 in FY 2024). Revenue: LK₨873.5m (up 11% from FY 2024). Net income: LK₨117.6m (up 5.1% from FY 2024). Profit margin: 14% (in line with FY 2024). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 37% per year, which means it is well ahead of earnings.
Reported Earnings • Jan 21Third quarter 2025 earnings released: EPS: LK₨1.84 (vs LK₨2.70 in 3Q 2024)Third quarter 2025 results: EPS: LK₨1.84 (down from LK₨2.70 in 3Q 2024). Revenue: LK₨253.4m (up 17% from 3Q 2024). Net income: LK₨29.0m (down 32% from 3Q 2024). Profit margin: 11% (down from 20% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Oct 25Second quarter 2025 earnings released: EPS: LK₨1.07 (vs LK₨0.092 loss in 2Q 2024)Second quarter 2025 results: EPS: LK₨1.07 (up from LK₨0.092 loss in 2Q 2024). Revenue: LK₨206.3m (up 12% from 2Q 2024). Net income: LK₨16.8m (up LK₨18.2m from 2Q 2024). Profit margin: 8.1% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 02First quarter 2025 earnings released: EPS: LK₨2.71 (vs LK₨0.90 in 1Q 2024)First quarter 2025 results: EPS: LK₨2.71 (up from LK₨0.90 in 1Q 2024). Revenue: LK₨173.4m (up 6.1% from 1Q 2024). Net income: LK₨42.5m (up 199% from 1Q 2024). Profit margin: 25% (up from 8.7% in 1Q 2024). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Reported Earnings • May 19Full year 2024 earnings released: EPS: LK₨7.11 (vs LK₨10.82 in FY 2023)Full year 2024 results: EPS: LK₨7.11 (down from LK₨10.82 in FY 2023). Revenue: LK₨789.0m (down 26% from FY 2023). Net income: LK₨111.7m (down 34% from FY 2023). Profit margin: 14% (down from 16% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Jan 18Third quarter 2024 earnings released: EPS: LK₨2.70 (vs LK₨1.42 in 3Q 2023)Third quarter 2024 results: EPS: LK₨2.70 (up from LK₨1.42 in 3Q 2023). Revenue: LK₨217.5m (down 1.6% from 3Q 2023). Net income: LK₨42.4m (up 90% from 3Q 2023). Profit margin: 20% (up from 10% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
Board Change • Feb 13High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Chairman of the Board Sumithra Anura Ekanayake is the most experienced director on the board, commencing their role in 2016. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
New Risk • Oct 14New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.4% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (22% accrual ratio). Market cap is less than US$10m (LK₨2.90b market cap, or US$9.58m). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (12% net profit margin). Revenue is less than US$5m (LK₨930m revenue, or US$3.1m).
Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to LK₨194, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 10x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 136% over the past three years.
New Risk • Aug 13New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (22% accrual ratio). Market cap is less than US$10m (LK₨2.67b market cap, or US$8.86m). Minor Risks Profit margins are more than 30% lower than last year (12% net profit margin). Revenue is less than US$5m (LK₨930m revenue, or US$3.1m).
Valuation Update With 7 Day Price Move • Jun 30Investor sentiment improves as stock rises 15%After last week's 15% share price gain to LK₨165, the stock trades at a trailing P/E ratio of 22x. Average trailing P/E is 9x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 249% over the past three years.
Upcoming Dividend • Jun 24Upcoming dividend of LK₨2.50 per shareEligible shareholders must have bought the stock before 01 July 2025. Payment date: 21 July 2025. Payout ratio is a comfortable 33% and the cash payout ratio is 80%. Trailing yield: 1.7%. Lower than top quartile of Sri Lankan dividend payers (5.4%). Lower than average of industry peers (4.7%).
Declared Dividend • May 29Dividend of LK₨2.50 announcedDividend of LK₨2.50 is the same as last year. Ex-date: 1st July 2025 Payment date: 21st July 2025 Dividend yield will be 1.6%, which is lower than the industry average of 8.6%. Sustainability & Growth Dividend is covered by both earnings (33% earnings payout ratio) and cash flows (56% cash payout ratio). The dividend has increased by an average of 9.6% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 63% to shift the payout ratio to a potentially unsustainable range, which is more than the 12% EPS decline seen over the last 5 years.
공시 • May 28Chemanex PLC announces Annual dividend, payable on July 21, 2025Chemanex PLC announced Annual dividend of LKR 2.5000 per share payable on July 21, 2025, ex-date on July 01, 2025 and record date on July 02, 2025.
공시 • May 27Chemanex PLC, Annual General Meeting, Jun 30, 2025Chemanex PLC, Annual General Meeting, Jun 30, 2025.
Reported Earnings • May 24Full year 2025 earnings released: EPS: LK₨7.48 (vs LK₨7.12 in FY 2024)Full year 2025 results: EPS: LK₨7.48 (up from LK₨7.12 in FY 2024). Revenue: LK₨873.5m (up 11% from FY 2024). Net income: LK₨117.6m (up 5.1% from FY 2024). Profit margin: 14% (in line with FY 2024). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 37% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment improves as stock rises 15%After last week's 15% share price gain to LK₨174, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 8x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 139% over the past three years.
Reported Earnings • Jan 21Third quarter 2025 earnings released: EPS: LK₨1.84 (vs LK₨2.70 in 3Q 2024)Third quarter 2025 results: EPS: LK₨1.84 (down from LK₨2.70 in 3Q 2024). Revenue: LK₨253.4m (up 17% from 3Q 2024). Net income: LK₨29.0m (down 32% from 3Q 2024). Profit margin: 11% (down from 20% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jan 02Investor sentiment improves as stock rises 16%After last week's 16% share price gain to LK₨185, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 7x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 151% over the past three years.
Valuation Update With 7 Day Price Move • Dec 17Investor sentiment improves as stock rises 26%After last week's 26% share price gain to LK₨123, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 7x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 82% over the past three years.
New Risk • Nov 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Sri Lankan stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 8.9% per year over the past 5 years. High level of non-cash earnings (27% accrual ratio). Market cap is less than US$10m (LK₨1.37b market cap, or US$4.71m). Minor Risks Dividend is not well covered by cash flows (382% cash payout ratio). Share price has been volatile over the past 3 months (5.4% average weekly change). Revenue is less than US$5m (LK₨821m revenue, or US$2.8m).
Reported Earnings • Oct 25Second quarter 2025 earnings released: EPS: LK₨1.07 (vs LK₨0.092 loss in 2Q 2024)Second quarter 2025 results: EPS: LK₨1.07 (up from LK₨0.092 loss in 2Q 2024). Revenue: LK₨206.3m (up 12% from 2Q 2024). Net income: LK₨16.8m (up LK₨18.2m from 2Q 2024). Profit margin: 8.1% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 02First quarter 2025 earnings released: EPS: LK₨2.71 (vs LK₨0.90 in 1Q 2024)First quarter 2025 results: EPS: LK₨2.71 (up from LK₨0.90 in 1Q 2024). Revenue: LK₨173.4m (up 6.1% from 1Q 2024). Net income: LK₨42.5m (up 199% from 1Q 2024). Profit margin: 25% (up from 8.7% in 1Q 2024). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
공시 • May 31Chemanex PLC, Annual General Meeting, Jun 28, 2024Chemanex PLC, Annual General Meeting, Jun 28, 2024.
Declared Dividend • May 30Dividend of LK₨2.50 announcedDividend of LK₨2.50 is the same as last year. Ex-date: 1st July 2024 Payment date: 18th July 2024 Dividend yield will be 2.9%, which is lower than the industry average of 8.6%. Sustainability & Growth Dividend is covered by earnings (58% earnings payout ratio) but not covered by cash flows (124% cash payout ratio). The dividend has increased by an average of 9.6% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 4.3% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Reported Earnings • May 19Full year 2024 earnings released: EPS: LK₨7.11 (vs LK₨10.82 in FY 2023)Full year 2024 results: EPS: LK₨7.11 (down from LK₨10.82 in FY 2023). Revenue: LK₨789.0m (down 26% from FY 2023). Net income: LK₨111.7m (down 34% from FY 2023). Profit margin: 14% (down from 16% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Apr 30Investor sentiment improves as stock rises 17%After last week's 17% share price gain to LK₨85.00, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 6x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 31% over the past three years.
Reported Earnings • Jan 18Third quarter 2024 earnings released: EPS: LK₨2.70 (vs LK₨1.42 in 3Q 2023)Third quarter 2024 results: EPS: LK₨2.70 (up from LK₨1.42 in 3Q 2023). Revenue: LK₨217.5m (down 1.6% from 3Q 2023). Net income: LK₨42.4m (up 90% from 3Q 2023). Profit margin: 20% (up from 10% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
Reported Earnings • Oct 21Second quarter 2024 earnings released: LK₨0.092 loss per share (vs LK₨3.36 profit in 2Q 2023)Second quarter 2024 results: LK₨0.092 loss per share (down from LK₨3.36 profit in 2Q 2023). Revenue: LK₨183.8m (down 48% from 2Q 2023). Net loss: LK₨1.40m (down 103% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
New Risk • Jul 28New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Sri Lankan stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.4% average weekly change). Earnings have declined by 27% per year over the past 5 years. Market cap is less than US$10m (LK₨1.41b market cap, or US$4.29m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (10% net profit margin). Revenue is less than US$5m (LK₨971m revenue, or US$3.0m).
Reported Earnings • Jul 21First quarter 2024 earnings released: EPS: LK₨0.90 (vs LK₨5.25 in 1Q 2023)First quarter 2024 results: EPS: LK₨0.90 (down from LK₨5.25 in 1Q 2023). Revenue: LK₨163.5m (down 36% from 1Q 2023). Net income: LK₨14.2m (down 83% from 1Q 2023). Profit margin: 8.7% (down from 32% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Jun 27Upcoming dividend of LK₨2.50 per share at 3.6% yieldEligible shareholders must have bought the stock before 04 July 2023. Payment date: 24 July 2023. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 3.6%. Lower than top quartile of Sri Lankan dividend payers (8.4%). Lower than average of industry peers (8.3%).
공시 • Jun 07Chemanex PLC, Annual General Meeting, Jun 30, 2023Chemanex PLC, Annual General Meeting, Jun 30, 2023, at 09:30 Sri Lanka Standard Time. Location: 9th Floor, Auditorium of Commercial Bank of Ceylon PLC, No.01, Union Place Colombo 02 Sri Lanka Agenda: To receive and adopt the statements of accounts of the company and of the group for the year ended 31st March 2023 together with the reports of the directors and auditors thereon; to declare a dividend as recommended by the directors; to reappoint Mr. E M M Boyagoda, who attained the age of 70 years on 29th April 2021, by passing the following Resolution of directors in terms of Section 211 of the Companies Act No. 7 of 2007; to reappoint M/s. Ernst & Young, Chartered Accountants as Auditors of the company and to authorise the directors to determine their remuneration; and to vote a sum as donations.
Reported Earnings • May 26Full year 2023 earnings released: EPS: LK₨10.82 (vs LK₨6.20 in FY 2022)Full year 2023 results: EPS: LK₨10.82 (up from LK₨6.20 in FY 2022). Revenue: LK₨1.06b (up 66% from FY 2022). Net income: LK₨169.9m (up 75% from FY 2022). Profit margin: 16% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Jan 18Third quarter 2023 earnings released: EPS: LK₨1.42 (vs LK₨1.52 in 3Q 2022)Third quarter 2023 results: EPS: LK₨1.42 (down from LK₨1.52 in 3Q 2022). Revenue: LK₨221.0m (up 37% from 3Q 2022). Net income: LK₨22.3m (down 6.7% from 3Q 2022). Profit margin: 10% (down from 15% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
Board Change • Dec 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Independent Director Ekanayake Mudiyanselage Boyagoda was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Nov 21Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to LK₨62.00, the stock trades at a trailing P/E ratio of 5.1x. Average trailing P/E is 4x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 14% over the past three years.
Board Change • Nov 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Independent Director Ekanayake Mudiyanselage Boyagoda was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 21Second quarter 2023 earnings released: EPS: LK₨3.36 (vs LK₨1.37 in 2Q 2022)Second quarter 2023 results: EPS: LK₨3.36 (up from LK₨1.37 in 2Q 2022). Revenue: LK₨351.2m (up 120% from 2Q 2022). Net income: LK₨52.8m (up 147% from 2Q 2022). Profit margin: 15% (up from 13% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to LK₨89.00, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 5x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 75% over the past three years.
Valuation Update With 7 Day Price Move • Aug 04Investor sentiment improved over the past weekAfter last week's 22% share price gain to LK₨64.50, the stock trades at a trailing P/E ratio of 6.4x. Average trailing P/E is 5x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 9.5% over the past three years.
Reported Earnings • Jul 21First quarter 2023 earnings released: EPS: LK₨5.25 (vs LK₨1.32 in 1Q 2022)First quarter 2023 results: EPS: LK₨5.25 (up from LK₨1.32 in 1Q 2022). Revenue: LK₨256.4m (up 81% from 1Q 2022). Net income: LK₨82.5m (up 296% from 1Q 2022). Profit margin: 32% (up from 15% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Jun 24Upcoming dividend of LK₨2.00 per shareEligible shareholders must have bought the stock before 01 July 2022. Payment date: 22 July 2022. Payout ratio is a comfortable 32% but the company is not cash flow positive. Trailing yield: 4.0%. Lower than top quartile of Sri Lankan dividend payers (9.4%). Lower than average of industry peers (7.9%).
Board Change • Jun 15Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Independent Director Ekanayake Mudiyanselage Boyagoda was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공시 • Jun 04Chemanex PLC, Annual General Meeting, Jun 30, 2022Chemanex PLC, Annual General Meeting, Jun 30, 2022, at 09:30 Sri Lanka Standard Time. Location: 199, Kew Road, Colombo 2 Colombo Sri Lanka Agenda: To receive and adopt the Statements of Accounts of the Company and of the Group for the year ended 31st March 2022 together with the Reports of the Directors and Auditors thereon; to consider dividend; to consider re-election of directors; to consider re-appointing M/s. Ernst & Young, Chartered Accountants as Auditors of the Company and to authorize the Directors to determine their remuneration; and to consider such other matters.
Reported Earnings • May 23Full year 2022 earnings released: EPS: LK₨6.20 (vs LK₨1.22 in FY 2021)Full year 2022 results: EPS: LK₨6.20 (up from LK₨1.22 in FY 2021). Revenue: LK₨639.7m (up 45% from FY 2021). Net income: LK₨97.4m (up 409% from FY 2021). Profit margin: 15% (up from 4.3% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • May 19Investor sentiment improved over the past weekAfter last week's 15% share price gain to LK₨65.00, the stock trades at a trailing P/E ratio of 14.6x. Average trailing P/E is 7x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 47% over the past three years.
Valuation Update With 7 Day Price Move • Mar 29Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to LK₨61.60, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 8x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 11% over the past three years.
Reported Earnings • Jan 23Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: LK₨1.52 (up from LK₨0.98 loss in 3Q 2021). Revenue: LK₨161.5m (up 42% from 3Q 2021). Net income: LK₨23.9m (up LK₨39.4m from 3Q 2021). Profit margin: 15% (up from net loss in 3Q 2021). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance.
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to LK₨115, the stock trades at a trailing P/E ratio of 59.1x. Average trailing P/E is 11x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 154% over the past three years.
Reported Earnings • Oct 23Second quarter 2022 earnings released: EPS LK₨1.37 (vs LK₨1.21 in 2Q 2021)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: LK₨159.7m (up 19% from 2Q 2021). Net income: LK₨21.4m (up 13% from 2Q 2021). Profit margin: 13% (in line with 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance.
Reported Earnings • Jul 22First quarter 2022 earnings released: EPS LK₨1.32 (vs LK₨0.74 in 1Q 2021)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2022 results: Revenue: LK₨141.8m (up 69% from 1Q 2021). Net income: LK₨20.8m (up 78% from 1Q 2021). Profit margin: 15% (in line with 1Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.
Upcoming Dividend • Jun 25Upcoming dividend of LK₨1.00 per shareEligible shareholders must have bought the stock before 01 July 2021. Payment date: 22 July 2021. Trailing yield: 1.3%. Lower than top quartile of Sri Lankan dividend payers (5.5%). Lower than average of industry peers (5.0%).
공시 • May 22+ 1 more updateChemanex PLC Recommends Final Dividend for the Year Ended March 31, 2021, Payable on 22 July 2021The Board of Directors of Chemanex PLC recommended a final dividend of LKR 1.00 per share amounting to LKR 15.71 million on the issued capital of Ordinary Shares for the year ended March 31, 2021, which is payable on 22 July 2021 if approved by the shareholders at the Annual General Meeting.
Is New 90 Day High Low • Feb 23New 90-day low: LK₨79.70The company is down 9.0% from its price of LK₨87.70 on 25 November 2020. The Sri Lankan market is up 26% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 59% over the same period.
Is New 90 Day High Low • Jan 27New 90-day high: LK₨103The company is up 51% from its price of LK₨67.90 on 29 October 2020. The Sri Lankan market is up 55% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 122% over the same period.
Is New 90 Day High Low • Jan 12New 90-day high: LK₨93.10The company is up 33% from its price of LK₨69.90 on 14 October 2020. The Sri Lankan market is up 24% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 40% over the same period.
Is New 90 Day High Low • Nov 23New 90-day high: LK₨92.60The company is up 63% from its price of LK₨56.70 on 25 August 2020. The Sri Lankan market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 53% over the same period.
Valuation Update With 7 Day Price Move • Nov 23Market bids up stock over the past weekAfter last week's 33% share price gain to LK₨92.60, the stock is trading at a trailing P/E ratio of 6.8x, up from the previous P/E ratio of 5.1x. This compares to an average P/E of 8x in the Chemicals industry in Sri Lanka. Total returns to shareholders over the past three years are 91%.
Valuation Update With 7 Day Price Move • Oct 20Market bids up stock over the past weekAfter last week's 18% share price gain to LK₨77.00, the stock is trading at a trailing P/E ratio of 5.7x, up from the previous P/E ratio of 4.8x. This compares to an average P/E of 9x in the Chemicals industry in Sri Lanka. Total returns to shareholders over the past three years are 45%.
Is New 90 Day High Low • Oct 15New 90-day high: LK₨76.20The company is up 62% from its price of LK₨46.90 on 17 July 2020. The Sri Lankan market is up 20% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 76% over the same period.
Valuation Update With 7 Day Price Move • Oct 15Market bids up stock over the past weekAfter last week's 20% share price gain to LK₨76.20, the stock is trading at a trailing P/E ratio of 5.6x, up from the previous P/E ratio of 4.7x. This compares to an average P/E of 7x in the Chemicals industry in Sri Lanka. Total returns to shareholders over the past three years are 45%.
Is New 90 Day High Low • Sep 24New 90-day high: LK₨64.00The company is up 20% from its price of LK₨53.20 on 26 June 2020. The Sri Lankan market is up 13% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 50% over the same period.